About Us

Dr. Govind Krishna stands as the visionary founder and driving force behind Aethelgard Genomics Pvt. Ltd. With a strong medical foundation and entrepreneurial spirit, he has transformed a bold idea into a fast-emerging pharmaceutical enterprise. His leadership combines medical insight with corporate strategy, ensuring that innovation and ethics remain at the core of the company’s mission.

As Chairman & CEO, he defines the long-term vision, builds strategic partnerships, and inspires a culture of excellence across all levels of the organization. Dr. Govind is deeply committed to making high-quality medicines accessible and affordable, while building a company that can compete with global pharma leaders. His strategic foresight continues to guide Aethelgard Genomics toward becoming a trusted name in the healthcare sector.

A dynamic finance leader with an MBA in Finance, Jackson Jose brings sharp financial acumen and strategic foresight to Aethelgard Genomics. As CFO, he manages financial planning, investment decisions, risk management, and compliance. His ability to balance growth with financial discipline makes him a cornerstone of the company’s leadership.

With expertise in corporate finance, taxation, and business analytics, Jackson ensures that every strategic initiative is financially sound and future-ready. His leadership ensures financial transparency and profitability, creating a strong backbone for the company’s ambitious expansion. Known for his analytical rigor and results-driven mindset, he plays a crucial role in shaping the financial destiny of Aethelgard Genomics.

Globally certified as a CMA (US), Arsha Raveendran is a financial strategist with a global perspective. She manages the company’s accounting, cost controls, audits, and financial reporting functions with precision and integrity. Her ability to optimize financial structures ensures that resources are utilized efficiently while maintaining compliance with the highest standards.

Arsha’s leadership in cost management and financial governance enables Aethelgard Genomics to compete aggressively in a cost-sensitive pharmaceutical market. She provides not only financial clarity but also business intelligence that drives decision-making at the highest levels. Her expertise ensures the company remains competitive, efficient, and resilient.

With a Master’s in Computer Applications and strong experience in digital solutions, Neena Jaganath leads the IT division with innovation and foresight. She is responsible for building a strong digital infrastructure that integrates seamlessly across operations, marketing, distribution, and finance.

Her expertise in CRM systems, data security, and IT automation enables the company to harness the power of technology in day-to-day business. By implementing cutting-edge digital platforms, she ensures real-time monitoring, operational transparency, and data-driven decision-making. Neena plays a critical role in positioning Aethelgard Genomics as a digitally forward pharmaceutical enterprise ready for global competition.

As Head of HR, Gokul Nair champions people strategy as the foundation of organizational success. He leads recruitment, training, employee engagement, and cultural development at Aethelgard Genomics. His mission is to build a workforce that is motivated, skilled, and aligned with the company’s values of integrity, innovation, and patient focus.

With his leadership, the HR department not only manages human capital but also nurtures talent for leadership succession, ensuring the company’s growth is sustainable. Gokul’s efforts in creating a positive work environment drive productivity, innovation, and employee loyalty, making HR a vital pillar of the organization’s long-term vision.

A postgraduate in Pharmaceutics (M.Pharm), Gowri Prasad brings scientific depth and precision to the critical areas of Quality Assurance and Quality Control. He ensures that every product leaving Aethelgard Genomics meets stringent national and international regulatory standards.

His expertise spans formulation, process validation, regulatory audits, and compliance management. With his guidance, the company not only assures product safety and efficacy but also builds long-term credibility with doctors, distributors, and patients. His commitment to quality ensures that Aethelgard Genomics stands for trust and excellence in every tablet produced.

An MBBS professional with deep knowledge of medical ethics and clinical practice, Dr. Abin Shajahan leads Medical Compliance at Aethelgard Genomics. He safeguards the company’s reputation by ensuring all products and operations adhere to medical standards, regulations, and ethical guidelines.

Dr. Abin bridges the gap between medical science and business, providing scientific validation for marketing strategies, product launches, and clinical communications. His oversight ensures that the company remains a responsible and trustworthy healthcare partner. With his medical expertise, Aethelgard Genomics gains credibility among healthcare professionals and regulatory bodies.

With a strong foundation in pharmaceutical sciences (B.Pharm), Rifa Rahim leads the twin functions of Product Development and Supply Chain. She plays a central role in selecting innovative formulations, coordinating with manufacturers, and ensuring efficient supply to the market.

Her role integrates scientific knowledge with operational agility, making sure products are not only high in quality but also delivered on time. By aligning product development with market needs, Rifa strengthens the company’s competitiveness. Her leadership ensures uninterrupted supply chains, efficient vendor management, and consistent growth in product portfolio.

A passionate leader in business growth, Sandra K Anilkumar heads Marketing & Sales with a results-driven approach. She is responsible for designing market strategies, expanding the company’s footprint, and building strong relationships with healthcare professionals.

Her expertise lies in blending modern marketing methods with traditional doctor engagement strategies to maximize outreach. Under her leadership, the sales force is empowered with training, digital tools, and clear goals. Sandra ensures that Aethelgard Genomics not only grows rapidly but also builds a strong, respected brand in the pharmaceutical market.

With an MBA from East London University, Shinu Shaji brings international business acumen and operational excellence to Aethelgard Genomics. As COO, he translates the company’s vision into actionable strategies, ensuring smooth coordination between departments.

His leadership focuses on operational efficiency, scalability, and strategic execution. Known for his ability to manage complexity, he ensures the company achieves milestones in finance, product launches, and market expansion. Shinu plays a pivotal role in transforming Aethelgard Genomics into a high-performance organization capable of competing with established pharma players.